Novartis's Zelmac to be released soon

Published: 2007-07-19 06:57:00
Updated: 2007-07-19 06:57:00
Zelmac, a drug used to treat irritable bowel syndrome, will be on the market shortly, according to Novartis Korea.

Sales of the drug have been temporarily halted from April owing its link to an increased risk of heart attacks and strokes. Previously, the US Food and Drug Administration pulled ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.